Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Long-term Remission of Advance...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Long-term Remission of Advanced Adrenocortical Carcinoma with KDR Gene Mutation Treated with Apatinib Mesylate: A Case Report

Long-term Remission of Advanced Adrenocortical Carcinoma with KDR Gene Mutation Treated with Apatinib Mesylate: A Case Report

Bibliographic Details
Main Authors: YANG Hui, ZHOU Li, LIU Biao, QIAN Jun
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2019-01-01
Series:Zhongliu Fangzhi Yanjiu
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.0400.htm
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.0400.htm

Similar Items

  • Apatinib mesylate tablet in the treatment of advanced malignant melanoma
    by: Yang L, et al.
    Published: (2018-08-01)
  • Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism
    by: Song ZZ, et al.
    Published: (2020-01-01)
  • Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report
    by: Lishu Yang, et al.
    Published: (2018-05-01)
  • Apatinib-treated advanced medullary thyroid carcinoma: a case report
    by: Chen K, et al.
    Published: (2018-01-01)
  • Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
    by: Zhi-Ran Yang, et al.
    Published: (2020-12-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...